Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Recent trends in hepatitis B virus infection in the general Korean population.

Kim H, Shin AR, Chung HH, Kim MK, Lee JS, Shim JJ, Kim BH.

Korean J Intern Med. 2013 Jul;28(4):413-9. doi: 10.3904/kjim.2013.28.4.413. Epub 2013 Jul 1.

2.

Trends in the seroprevalence of hepatitis B surface antigen in the South Korean population.

Park SH.

Int J Infect Dis. 2012 Sep;16(9):e669-72. doi: 10.1016/j.ijid.2012.05.1019. Epub 2012 Jun 26.

3.
4.

Seroepidemiology of hepatitis B virus infection and impact of vaccination.

Huang P, Zhu LG, Zhu YF, Yue M, Su J, Zhu FC, Yang HT, Zhang Y, Shen HB, Yu RB, Zhai XJ, Peng ZH.

World J Gastroenterol. 2015 Jul 7;21(25):7842-50. doi: 10.3748/wjg.v21.i25.7842.

5.

Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages.

Whittle HC, Maine N, Pilkington J, Mendy M, Fortuin M, Bunn J, Allison L, Howard C, Hall A.

Lancet. 1995 Apr 29;345(8957):1089-92.

PMID:
7715343
6.

Changes in the intrafamilial transmission of hepatitis B virus after introduction of a hepatitis B vaccination programme in Korea.

Jeong SH, Yim HW, Yoon SH, Jee YM, Bae SH, Lee WC.

Epidemiol Infect. 2010 Aug;138(8):1090-5. doi: 10.1017/S0950268809991324. Epub 2009 Dec 2.

PMID:
19951454
7.

Changes in seroprevalence of hepatitis B surface antigen and epidemiologic characteristics in the Republic of Korea, 1998-2013.

Lee H, Lee H, Cho Y, Oh K, Ki M.

Epidemiol Health. 2015 Dec 23;37:e2015055. doi: 10.4178/epih/e2015055. eCollection 2015.

8.

Survey of perinatal hepatitis B virus transmission after Korean National Prevention Program in a tertiary hospital.

Kim JH, Kim JS, Lee JJ, Kim JH, Kim SY, Jung YK, Kwon OS, Kim YS, Choi DJ, Kim JH.

Korean J Intern Med. 2014 May;29(3):307-14. doi: 10.3904/kjim.2014.29.3.307. Epub 2014 Apr 29.

9.

Impacts of vaccination on hepatitis B viral infections in Korea over a 25-year period.

Park NH, Chung YH, Lee HS.

Intervirology. 2010;53(1):20-8. doi: 10.1159/000252780. Epub 2010 Jan 5. Review.

PMID:
20068337
10.

Prevalence and risk factors of hepatitis B and C virus infections among the general population and blood donors in Morocco.

Baha W, Foullous A, Dersi N, They-they TP, El alaoui K, Nourichafi N, Oukkache B, Lazar F, Benjelloun S, Ennaji MM, Elmalki A, Mifdal H, Bennani A.

BMC Public Health. 2013 Jan 18;13:50. doi: 10.1186/1471-2458-13-50.

11.

Serological prevalence of hepatitis B virus and hepatitis C virus infection in the elderly population: Polish nationwide survey--PolSenior.

Hartleb M, Gutkowski K, Zejda JE, Chudek J, Więcek A.

Eur J Gastroenterol Hepatol. 2012 Nov;24(11):1288-95.

PMID:
22864260
12.

A population-based study examining hepatitis B virus infection and immunization rates in Northwest China.

Ji Z, Wang T, Shao Z, Huang D, Wang A, Guo Z, Long Y, Zhang L, Su H, Zhang Q, Yan Y, Fan D.

PLoS One. 2014 May 15;9(5):e97474. doi: 10.1371/journal.pone.0097474. eCollection 2014.

13.

Ten-Year Changes in the Hepatitis B Prevalence in the Birth Cohorts in Korea: Results From Nationally Representative Cross-Sectional Surveys.

Park B, Jung KW, Oh CM, Choi KS, Suh M, Jun JK.

Medicine (Baltimore). 2015 Oct;94(41):e1469. doi: 10.1097/MD.0000000000001469.

14.

[Current seroprevalence, vaccination and predictive value of liver enzymes for hepatitis B among refugees in Germany].

Hampel A, Solbach P, Cornberg M, Schmidt RE, Behrens GM, Jablonka A.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2016 May;59(5):578-83. doi: 10.1007/s00103-016-2333-8. German.

PMID:
27090247
15.

Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination.

Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, Wang F, Zheng H, Wang F, Guo J, Jia Z, Ma J, Wang H, Luo H, Li L, Jin S, Hadler SC, Wang Y.

Vaccine. 2009 Nov 5;27(47):6550-7. doi: 10.1016/j.vaccine.2009.08.048. Epub 2009 Sep 1.

PMID:
19729084
16.

Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination.

Ni YH, Chang MH, Huang LM, Chen HL, Hsu HY, Chiu TY, Tsai KS, Chen DS.

Ann Intern Med. 2001 Nov 6;135(9):796-800.

PMID:
11694104
17.

Markers of hepatitis B infection in Tari District, Southern Highlands Province, Papua New Guinea.

Sanders RC, Lewis D, Dyke T, Alpers MP.

P N G Med J. 1992 Sep;35(3):197-201.

PMID:
1296422
18.

Prevalence, risk factors and genotypes of hepatitis B infection among HIV-infected patients in the State of MS, Central Brazil.

Freitas SZ, Soares CC, Tanaka TS, Lindenberg AS, Teles SA, Torres MS, Mello FC, Mendes-Corrêa MC, Savassi-Ribas F, Motta-Castro AR.

Braz J Infect Dis. 2014 Sep-Oct;18(5):473-80. doi: 10.1016/j.bjid.2014.01.005. Epub 2014 Mar 22.

19.

[Preliminary analysis on the prevalence and causes of breakthrough hepatitis B virus infection among children in Shandong province, China].

Zhang L, Yan BY, Li MS, Song LZ, Lü JJ, Xu Q, Xu AQ.

Zhonghua Yu Fang Yi Xue Za Zhi. 2013 Oct;47(10):933-9. Chinese.

PMID:
24378135
20.

Supplemental Content

Support Center